Mechanisms regulating immune surveillance of cellular stress in cancer

The purpose of this review is to explore immune-mediated mechanisms of stress surveillance in cancer, with particular emphasis on the idea that all cancers have classical hallmarks (Hanahan and Weinberg in Cell 100:57–70, 67; Cell 144:646–674, 68) that could be interrelated. We postulate that hallmarks of cancer associated with cellular stress pathways (Luo et al. in Cell 136:823–837, 101) including oxidative stress, proteotoxic stress, mitotic stress, DNA damage, and metabolic stress could define and modulate the inflammatory component of cancer. As such, the overarching goal of this review is to define the types of cellular stress that cancer cells undergo, and then to explore mechanisms by which immune cells recognize, respond to, and are affected by each stress response.

[1]  T. Giese,et al.  A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation. , 2008, Gastroenterology.

[2]  H. Petty,et al.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. , 2007, Experimental eye research.

[3]  William A Weiss,et al.  Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.

[4]  Xiangshi Tan,et al.  Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response , 2016, Scientific Reports.

[5]  O. Finn,et al.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. , 2001, Cancer research.

[6]  D. Bull,et al.  Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[7]  R. Dutton,et al.  Immunization of Normal Mouse Spleen Cell Suspensions in vitro , 1966, Science.

[8]  P. Fisher,et al.  Activation of the MDA-5-IPS-1 Viral Sensing Pathway Induces Cancer Cell Death and Type I IFN-Dependent Antitumor Immunity. , 2016, Cancer research.

[9]  P. Szankasi,et al.  Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+ Effector T Cells , 2011, PloS one.

[10]  S. Martin,et al.  The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond. , 2015, Seminars in cancer biology.

[11]  C. Coch,et al.  Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells , 2011, European journal of immunology.

[12]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[13]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[14]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[15]  Michael O. Kelleher,et al.  Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway , 2002, Oncogene.

[16]  H. Simon.  Neutrophil apoptosis pathways and their modifications in inflammation , 2003, Immunological reviews.

[17]  P. Duewell,et al.  Breaking tumor-induced immunosuppression with 5′-triphosphate siRNA silencing TGFβ and activating RIG-I , 2013, Oncoimmunology.

[18]  F. Di Virgilio,et al.  Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.

[19]  S. Gasser,et al.  ATM activation mediates anticancer immunosurveillance by natural killer and T cells , 2013, Oncoimmunology.

[20]  M. Zanetti,et al.  Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells , 2011, Proceedings of the National Academy of Sciences.

[21]  Y. Ben-Neriah,et al.  Senescence-associated inflammatory responses: aging and cancer perspectives. , 2015, Trends in immunology.

[22]  S. Campello,et al.  Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents , 2016, Oncotarget.

[23]  D. Lawrence,et al.  Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. , 1987, Experimental cell research.

[24]  Jianbin Wang,et al.  JNK signaling is needed to tolerate chromosomal instability , 2014, Cell cycle.

[25]  Zhi-ren Zhang,et al.  Macrophages in Tumor Microenvironments and the Progression of Tumors , 2012, Clinical & developmental immunology.

[26]  G. Berchem,et al.  Autophagy: an adaptive metabolic response to stress shaping the antitumor immunity. , 2014, Biochemical pharmacology.

[27]  K. Hellstrand,et al.  NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species , 2006, British journal of haematology.

[28]  S. Bhattacharyya,et al.  Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. , 2007, Cancer research.

[29]  R. Taboła,et al.  Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. , 2015, Cancer letters.

[30]  M. Hurme,et al.  Pre-exposure to oxidative stress decreases the nuclear factor-kappa B-dependent transcription in T lymphocytes. , 1998, Journal of immunology.

[31]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[32]  H. Clevers,et al.  Immunosurveillance against tetraploidization-induced colon tumorigenesis , 2013, Cell cycle.

[33]  G. Filomeni,et al.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Yan A. Su,et al.  Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma , 1997, Oncogene.

[35]  R. Benezra,et al.  The cancer biology of whole-chromosome instability , 2013, Oncogene.

[36]  Eric J. Brown,et al.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor , 2005, Nature.

[37]  D. Mougiakakos,et al.  Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. , 2011, Blood.

[38]  C. Rao,et al.  Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis , 2012, Cell cycle.

[39]  G. Barber,et al.  Diverse roles of STING-dependent signaling on the development of cancer , 2015, Oncogene.

[40]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[41]  Z. Werb,et al.  Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen. , 1982, The Journal of clinical investigation.

[42]  G. Barber,et al.  Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis. , 2016, Cell reports.

[43]  P. van Endert,et al.  Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death , 2009, The EMBO journal.

[44]  Heather R. Roberts,et al.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. , 2009, Carcinogenesis.

[45]  O. Warburg.  On the origin of cancer cells. , 1956, Science.

[46]  H. Ishwaran,et al.  Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade , 2016, Cell.

[47]  D. Choubey,et al.  AIM2, an IFN-Inducible Cytosolic DNA Sensor, in the Development of Benign Prostate Hyperplasia and Prostate Cancer , 2013, Molecular Cancer Research.

[48]  L. Oberley,et al.  Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation , 2002, The Journal of experimental medicine.

[49]  R. Holmdahl,et al.  Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.

[50]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[51]  R. Saint,et al.  Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll , 2015, Oncotarget.

[52]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[53]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[54]  R. Weichselbaum,et al.  RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation , 2014, Proceedings of the National Academy of Sciences.

[55]  M. Santoro,et al.  ROS homeostasis and metabolism: a dangerous liason in cancer cells , 2016, Cell Death and Disease.

[56]  A. Ravid,et al.  Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Means,et al.  Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response , 2014, Nature.

[58]  Wei Wang,et al.  Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response , 2015, Cell Research.

[59]  A. Luciano,et al.  Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer , 2012, The Journal of Immunology.

[60]  J. Roder,et al.  Involvement of hydroxyl free radical, but not superoxide, in the cytolytic pathway of natural killer cells. Revision of an earlier hypothesis. , 1984, Medical biology.

[61]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[62]  R. Kiessling,et al.  Inhibition of Activated/Memory (CD45RO+) T Cells by Oxidative Stress Associated with Block of NF-κB Activation1 , 2001, The Journal of Immunology.

[63]  Jinhai Gao,et al.  Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors , 2004, Nature.

[64]  H. Lederman,et al.  Effects of hypoxia on interleukin‐2 mRNA expression by T lymphocytes , 1994, Critical care medicine.

[65]  L. Avanesyan,et al.  Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients , 2014, Proceedings of the National Academy of Sciences.

[66]  W. Ladiges,et al.  Breast tumor cells primed by endoplasmic reticulum stress remodel macrophage phenotype. , 2013, American journal of cancer research.

[67]  Sandro Santagata,et al.  A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas , 2005, PLoS genetics.

[68]  M. Zanetti,et al.  The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells , 2016, Oncogene.

[69]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[70]  P. Sinha,et al.  Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. , 2010, Cancer research.

[71]  D. Agrawal,et al.  Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. , 2017, Anticancer research.

[72]  C. Nathan,et al.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages , 1975, The Journal of experimental medicine.

[73]  Juan R. Cubillos-Ruiz,et al.  Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer , 2017, Cell.

[74]  M. Schön.  TLR7 and TLR8 as targets in cancer therapy , 2008, Oncogene.

[75]  L. Zitvogel,et al.  Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.

[76]  Ying Wang,et al.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. , 2014, Immunity.

[77]  P. Rustin,et al.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.

[78]  S. Klebanoff,et al.  Augmentation of spontaneous macrophage-mediated cytolysis by eosinophil peroxidase , 1982, The Journal of experimental medicine.

[79]  B. Arrick,et al.  Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis , 1981, The Journal of experimental medicine.

[80]  Y. Wan,et al.  Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy , 2007, Clinical Cancer Research.

[81]  Chendong Yang,et al.  Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation 1 , 2003, The Journal of Immunology.

[82]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[83]  C. Sautès-Fridman,et al.  TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer. , 2014, Cancer research.

[84]  Brianne R. Barker,et al.  Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt , 2015, Nature Medicine.

[85]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[86]  K. Gupta,et al.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer , 2007, Nature Medicine.

[87]  D. Lin,et al.  Fen1 mutations result in autoimmunity, chronic inflammation and cancers , 2007, Nature Medicine.

[88]  J. Montoya,et al.  [Diseases of mitochondrial DNA]. , 2000, Revista de neurologia.

[89]  I. Braakman,et al.  Protein folding and modification in the mammalian endoplasmic reticulum. , 2011, Annual review of biochemistry.

[90]  A. Cuervo,et al.  Macroautophagy Regulates Energy Metabolism during Effector T Cell Activation , 2010, The Journal of Immunology.

[91]  K. Selander,et al.  Toll-Like Receptor 9 in Breast Cancer , 2014, Front. Immunol..

[92]  Odilo Trabold,et al.  Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[93]  S. Buus,et al.  Oxidative stress can alter the antigenicity of immunodominant peptides , 2009, Journal of leukocyte biology.

[94]  J. Daly.  A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish , 2010 .

[95]  U. Mellqvist,et al.  Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. , 2000, Blood.

[96]  S. Endres,et al.  RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells , 2014, Cell Death and Differentiation.

[97]  P. Srivastava,et al.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. , 2001, Immunity.

[98]  David A Hildeman,et al.  Sensitization of T cells to apoptosis—A role for ROS? , 2004, Apoptosis.

[99]  C. Graham,et al.  A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. , 2014, Cancer research.

[100]  M. Karin.  NF-kappaB as a critical link between inflammation and cancer. , 2009, Cold Spring Harbor perspectives in biology.

[101]  J. Zimmer,et al.  Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia , 2013, Proceedings of the National Academy of Sciences.

[102]  T. Luedde,et al.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development , 2011, Nature.

[103]  C. Nathan,et al.  Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages , 1980, The Journal of experimental medicine.

[104]  J. Miyoshi,et al.  Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells , 2007, Proceedings of the National Academy of Sciences.

[105]  S. Gasser,et al.  The DNA damage response arouses the immune system. , 2006, Cancer research.

[106]  M. Delorenzi,et al.  Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy , 2014, Nature Medicine.

[107]  Dhiraj Kumar,et al.  The Strength of Receptor Signaling Is Centrally Controlled through a Cooperative Loop between Ca2+ and an Oxidant Signal , 2005, Cell.

[108]  B. Ammori,et al.  Myeloid‐derived suppressor cells in cancer: recent progress and prospects , 2013, Immunology and cell biology.

[109]  J. Deursen.  The role of senescent cells in ageing , 2014, Nature.

[110]  Arthur M. Krieg,et al.  Toll-like receptor 9 (TLR9) agonists in the treatment of cancer , 2008, Oncogene.

[111]  J. Kipnis,et al.  Extracellular Redox Modulation by Regulatory T Cells† , 2009, Nature chemical biology.

[112]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[113]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[114]  P. Anderson,et al.  Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity , 1996, European journal of immunology.

[115]  J. Roder,et al.  Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step. , 1985, Journal of immunology.

[116]  Yong-mei Yang,et al.  Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A2 , 2010, Cellular and Molecular Immunology.

[117]  A. Garg,et al.  Targeting ER stress induced apoptosis and inflammation in cancer. , 2013, Cancer letters.

[118]  S. Klebanoff.  Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[119]  C. Graham,et al.  Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide. , 2008, Cancer research.

[120]  S. Gregory,et al.  Sterile Inflammation in Drosophila , 2015, Mediators of inflammation.

[121]  B. Chain,et al.  Reactive oxygen species activate human peripheral blood dendritic cells. , 1999, Free radical biology & medicine.

[122]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[123]  Aline Bittencourt,et al.  Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets. , 2012, The Journal of endocrinology.

[124]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[125]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[126]  Svetlana Shulga Morskaya,et al.  5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma , 2008, Nature Medicine.

[127]  H. Fujii,et al.  H2O2 production within tumor microenvironment inversely correlated with infiltration of CD56dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction , 2011, Cancer Immunology, Immunotherapy.

[128]  G. Cline,et al.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.

[129]  Jennifer Couzin-Frankel,et al.  Breakthrough of the year 2013. Cancer immunotherapy. , 2013, Science.

[130]  L. Davis,et al.  Oxidative Stress Promotes Polarization of Human T Cell Differentiation Toward a T Helper 2 Phenotype1 , 2006, The Journal of Immunology.

[131]  F. Urano,et al.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.

[132]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[133]  Gregor Rothe,et al.  Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.

[134]  S. Jones,et al.  Many roads lead to oncogene-induced senescence , 2008, Oncogene.

[135]  K. Rouschop,et al.  Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells , 2013, PloS one.

[136]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[137]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[138]  M. Kloor,et al.  Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients , 2014, International journal of cancer.

[139]  J. Morrow,et al.  Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. , 2003, The Journal of clinical investigation.

[140]  N. Reich,et al.  The DNA Damage Response Induces IFN , 2011, The Journal of Immunology.

[141]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[142]  M. Smyth,et al.  NKG2D function protects the host from tumor initiation , 2005, The Journal of experimental medicine.

[143]  D. Gabrilovich.  Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[144]  John J. Cole,et al.  Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest , 2015, Cell reports.

[145]  Si Ming Man,et al.  Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation , 2014, The Journal of Immunology.

[146]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[147]  Jing Deng,et al.  Translational Repression Mediates Activation of Nuclear Factor Kappa B by Phosphorylated Translation Initiation Factor 2 , 2004, Molecular and Cellular Biology.

[148]  R. Kaufman,et al.  ER stress and the unfolded protein response. , 2005, Mutation research.

[149]  Duwe Ak,et al.  Involvement of hydroxyl free radical, but not superoxide, in the cytolytic pathway of natural killer cells. Revision of an earlier hypothesis. , 1984 .

[150]  M. Suthanthiran,et al.  Hydroxyl radical scavengers inhibit human natural killer cell activity , 1984, Nature.

[151]  K. Porter,et al.  CYTOPLASMIC COMPONENTS IN HEPATIC CELL LYSOSOMES , 1962, The Journal of cell biology.

[152]  J. Ledermann,et al.  Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor , 2008, Clinical Cancer Research.

[153]  Geert J. P. L. Kops,et al.  On the road to cancer: aneuploidy and the mitotic checkpoint , 2005, Nature Reviews Cancer.

[154]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[155]  F. Mitelman,et al.  Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .

[156]  T. Whiteside,et al.  The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). , 2011, Current medicinal chemistry.

[157]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[158]  J. Roder,et al.  Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells , 1982, Nature.

[159]  S. Akira,et al.  Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs , 2016, Oncotarget.

[160]  R. Foà,et al.  ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. , 2009, Blood.

[161]  K. Hellstrand,et al.  Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. , 1994, Journal of immunology.

[162]  E. Celis,et al.  Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors , 2014, Clinical Cancer Research.

[163]  O. Harismendy,et al.  Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. , 2016, Cell reports.

[164]  S. Lowe,et al.  p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells , 2013, The Journal of experimental medicine.

[165]  Robert A. Carter,et al.  Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer , 2015, Cell.

[166]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[167]  E. Elinav,et al.  The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury , 2016, Science.

[168]  V. Bronte,et al.  L-arginine metabolism in myeloid cells controls T-lymphocyte functions. , 2003, Trends in immunology.

[169]  P. Oefner,et al.  Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes , 2009, The Journal of Immunology.

[170]  G. Cheng,et al.  Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. , 2010, Cancer research.

[171]  J. Lindenmann,et al.  Virus interference. I. The interferon. , 1987, Proceedings of the Royal Society of London. Series B, Biological sciences.

[172]  B. Suarez-Alvarez,et al.  The NKG2D receptor: sensing stressed cells. , 2008, Trends in molecular medicine.

[173]  Ming Li,et al.  An Immunosurveillance Mechanism Controls Cancer Cell Ploidy , 2012, Science.

[174]  T. Curiel,et al.  Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.

[175]  J. Engh,et al.  IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. , 2016, Neuro-oncology.

[176]  D. Bull,et al.  Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[177]  R. Schreiber,et al.  Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells , 2009, The Journal of experimental medicine.

[178]  P. Ghezzi,et al.  Thioredoxin, a Redox Enzyme Released in Infection and Inflammation, Is a Unique Chemoattractant for Neutrophils, Monocytes, and T Cells , 1999, The Journal of experimental medicine.

[179]  P. Schumacker.  Reactive oxygen species in cancer: a dance with the devil. , 2015, Cancer cell.

[180]  D. Gabrilovich,et al.  Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species , 2003, Journal of leukocyte biology.

[181]  L. Battistini,et al.  TLR Stimulation of Prostate Tumor Cells Induces Chemokine-Mediated Recruitment of Specific Immune Cell Types , 2010, The Journal of Immunology.

[182]  M. Smyth,et al.  Molecular mechanisms of natural killer cell activation in response to cellular stress , 2013, Cell Death and Differentiation.

[183]  C. Rao,et al.  Emerging links among Chromosome Instability (CIN), cancer, and aging , 2017, Molecular carcinogenesis.

[184]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[185]  K. Hellstrand,et al.  Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. , 1996, Journal of immunology.

[186]  B. Bonnotte,et al.  Myeloid‐derived suppressor cells from tumor‐bearing mice impair TGF‐β‐induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25−FoxP3− T cells , 2012, Journal of leukocyte biology.

[187]  R. Weichselbaum,et al.  Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. , 2014, Cancer cell.

[188]  G. Hartmann,et al.  Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. , 2013, Cancer research.

[189]  M. Zanetti,et al.  Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming , 2012, PloS one.

[190]  A. Santoni,et al.  The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells , 2014, Front. Immunol..

[191]  C. López-Larrea,et al.  Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors , 2016, Oncoimmunology.

[192]  M. Dimopoulos,et al.  DNA damage, tumor mutational load and their impact on immune responses against cancer. , 2016, Annals of translational medicine.

[193]  P. Chu,et al.  TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy. , 2013, Cancer research.

[194]  A. Santoni,et al.  Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma , 2013, Oncoimmunology.

[195]  T. Junt,et al.  Triggering the succinate receptor GPR91 on dendritic cells enhances immunity , 2008, Nature Immunology.

[196]  S. Gasser,et al.  The DNA damage response induces antigen presenting cell‐like functions in fibroblasts , 2014, European journal of immunology.

[197]  H. Pahl,et al.  Activation of NF‐κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers , 1996, FEBS letters.

[198]  I. Clark,et al.  Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. , 1986, Journal of immunology.

[199]  I. Clark,et al.  Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. , 1988, Cellular immunology.